Bolhuis, M. S., Akkerman, O. W., Sturkenboom, M. G. G., Ghimire, S., Srivastava, S., Gumbo, T., & Alffenaar, J. C. (2018). Linezolid-based Regimens for Multidrug-resistant Tuberculosis (TB): A Systematic Review to Establish or Revise the Current Recommended Dose for TB Treatment. Clinical infectious diseases, 67(suppl_3), S327. https://doi.org/10.1093/cid/ciy625
Chicago-Zitierstil (17. Ausg.)Bolhuis, Mathieu S., Onno W. Akkerman, Marieke G G. Sturkenboom, Samiksha Ghimire, Shashikant Srivastava, Tawanda Gumbo, und Jan-Willem C. Alffenaar. "Linezolid-based Regimens for Multidrug-resistant Tuberculosis (TB): A Systematic Review to Establish or Revise the Current Recommended Dose for TB Treatment." Clinical Infectious Diseases 67, no. suppl_3 (2018): S327. https://doi.org/10.1093/cid/ciy625.
MLA-Zitierstil (9. Ausg.)Bolhuis, Mathieu S., et al. "Linezolid-based Regimens for Multidrug-resistant Tuberculosis (TB): A Systematic Review to Establish or Revise the Current Recommended Dose for TB Treatment." Clinical Infectious Diseases, vol. 67, no. suppl_3, 2018, p. S327, https://doi.org/10.1093/cid/ciy625.